Introduction to biosimilars for immune-mediated inflammatory diseases: 2022 update

Am J Manag Care. 2022 Nov;28(12 Suppl):S215-S216. doi: 10.37765/ajmc.2022.89295.
No abstract available

MeSH terms

  • Biosimilar Pharmaceuticals* / therapeutic use
  • Humans
  • Inflammatory Bowel Diseases*

Substances

  • Biosimilar Pharmaceuticals